About this Event
Jason DeHart, Ph.D., Dispatch Biotherapeutics
"A Universal Approach to Solid Tumors Using Tumor-Specific Virus and CAR T Combination Therapy"
Jason Lamontagne, Ph.D., GEMMA Biotherapeutics
"A Disease-Agnostic, Platform-Based Gene Editing Approach to Treat Rare Monogenic Diseases"
Doors open at 3:30 p.m. Program begins promptly at 4 p.m. Reception follows from 5 to 6 p.m.
Event Venue & Nearby Stays
The Wistar Institute, 3601 Spruce Street, Philadelphia, United States
USD 0.00












